A study of 288,907 insured people found other medical costs rose about 22 cents per drug dollar. Also covers Medicare's $245 Bridge price and employer cutbacks.
Recap by typeshit. Full story at https://www.celinegounder.com/.
Business Day says medicines endorsed by the WHO still aren't available to public sector patients. The drugs involved aren't named in the share.
ASU's Justin Bina told the New York Post that people starting GLP-1 drugs become willing to pay more per pound for certain proteins, even as cattle stocks hit a 75-year low.
Zacks expects $10.1 billion from Mounjaro and $5.1 billion from Zepbound, and notes Lilly plans to seek retatrutide approval in early 2027.
A WTW survey puts employer coverage at 53%, down from 57%. CNBC lays out what workers can turn to instead, from LillyDirect and NovoCare to reimbursement plans.
Medical Xpress covers work on blocking an enzyme in fat cells, framed against US adult obesity rates above 40% between 2021 and 2023.
Bikman cites a four-week trial in young men eating about 40% under their needs, where the high-protein group added lean mass and shed more fat.
Loading…